Skip to main content

Table 1 Patient and tumor characteristics

From: Latissimus dorsi myocutaneous flap repair is effective after neoadjuvant chemotherapy for locally advanced breast cancer

Variable Value P value
Age (year), median (range) 47.35 ± 3.97 (40–55) ≥ 0.05
Smoking, n (%)   ≥ 0.05
 Yes 7(5%)  
 No 135(95%)  
BMI, median (range) 25.03 ± 2.1(20–32) ≥ 0.05
Follow-up (months), median (range) 16.5 ± 3.73(12–24) ≥ 0.05
Menopausal status, n (%)   ≥ 0.05
Premenopausal 47(33%)  
Post-menopausal 95(67%)  
Stage of disease, n (%)   ≤ 0.05
 IIB 19(13%)  
 IIIA 31(22%)  
 IIIB 39(28%)  
 IIIC 53(37%)  
Tumor classification, n (%)   ≤ 0.001
 T1 0  
 T2 0  
 T3 36(25%)  
 T4 106(75%)  
Lymph node status, n (%)   ≤ 0.05
 N0 0  
 N1 48(34%)  
 N2/N3 94(66%)  
ER, PR status at initial diagnosis, n (%)   ≥ 0.05
 Positive 90(63.4%)  
 Negative 52(33.6%)  
HER-2 status at initial diagnosis   ≥ 0.05
 Positive 41(28.9%)  
 Negative 101(71.1%)  
Surgical margin status, n (%)   ≥ 0.05
 Positive 2(1%)  
 Negative 140(99%)  
Skin invasion and ulceration, n (%)   
 Yes 106(75%)  
 No 36(25%)  
Pectoralis major   
 Yes 53(37%)  
 No 89(63%)  
Histological type, n (%)   
Infiltrating ductal carcinoma 138(97%)  
Inflammatory 4(3%)  
Molecular subtyping, n (%)   ≤ 0.05
 Luminal A 38(26.8%)  
 Luminal B 52(36.6%)  
Triplenegative 31(21.8%)  
HER-2 overexpression 21(14.8%)